What's New on the FDA Drugs Site

June 15, 2011

Drug Shortages: Current Drug Shortages: Etoposide solution for injection (updated)
Drugs@FDA Download File (updated)
FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer
National Drug Code Directory (updated)
New and Generic Drug Approvals

June 15, 2011

Alkeran (melphalan hydrochloride) Injection, GlaxcoSmithKline, Labeling Revision
Alkeran (melphalan) Tablets, GlaxcoSmithKline, Labeling Revision
Bupropion Hydrochloride Extended-Release Tablets, Anchen Pharmaceuticals, Inc., Approval
Bupropion Hydrochloride Extended-release Tablets (150mg), Anchen Pharmaceuticals, Inc., Approval
Cipro (ciprofloxacin hydrochloride) Tablets, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
Cipro (ciprofloxacin) Oral Suspension, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
Cipro XR (ciprofloxacin) Extended-Release Tablets, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
Clolar (clofarabine) I.V. Injection, Genzyme Corp., Labeling Revision
Creon (pancrelipase) Delayed-Release Capsules, Abbott Products Inc., Manufacturing Supplement
Doxycycline Hyclate Delayed-Release Tablets, Mylan Pharmaceuticals Inc., Tentative Approval
Potiga (ezogabine) Tablets, Valeant Pharmaceuticals, Approval
Zenpep (pancrelipase) Delayed-Release Capsules, Eurand Pharmaceuticals, Inc., Labeling Revision